These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 27297108)

  • 21. Structural insights into the interaction of human S100B and basic fibroblast growth factor (FGF2): Effects on FGFR1 receptor signaling.
    Gupta AA; Chou RH; Li H; Yang LW; Yu C
    Biochim Biophys Acta; 2013 Dec; 1834(12):2606-19. PubMed ID: 24063890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain S100A5 is a novel calcium-, zinc-, and copper ion-binding protein of the EF-hand superfamily.
    Schäfer BW; Fritschy JM; Murmann P; Troxler H; Durussel I; Heizmann CW; Cox JA
    J Biol Chem; 2000 Sep; 275(39):30623-30. PubMed ID: 10882717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Trp triad within the V-domain of the receptor for advanced glycation end products modulates folding, stability and ligand binding.
    Indurthi VSK; Jensen JL; Leclerc E; Sinha S; Colbert CL; Vetter SW
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31912881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and characterization of small molecule inhibitors of the calcium-dependent S100B-p53 tumor suppressor interaction.
    Markowitz J; Chen I; Gitti R; Baldisseri DM; Pan Y; Udan R; Carrier F; MacKerell AD; Weber DJ
    J Med Chem; 2004 Oct; 47(21):5085-93. PubMed ID: 15456252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural and functional insights into RAGE activation by multimeric S100B.
    Ostendorp T; Leclerc E; Galichet A; Koch M; Demling N; Weigle B; Heizmann CW; Kroneck PM; Fritz G
    EMBO J; 2007 Aug; 26(16):3868-78. PubMed ID: 17660747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solution structure and dynamics of S100A5 in the apo and Ca2+-bound states.
    Bertini I; Das Gupta S; Hu X; Karavelas T; Luchinat C; Parigi G; Yuan J
    J Biol Inorg Chem; 2009 Sep; 14(7):1097-107. PubMed ID: 19536568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amlexanox Blocks the Interaction between S100A4 and Epidermal Growth Factor and Inhibits Cell Proliferation.
    Cho CC; Chou RH; Yu C
    PLoS One; 2016; 11(8):e0161663. PubMed ID: 27559743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RAGE Mediates the Pro-Migratory Response of Extracellular S100A4 in Human Thyroid Cancer Cells.
    Medapati MR; Dahlmann M; Ghavami S; Pathak KA; Lucman L; Klonisch T; Hoang-Vu C; Stein U; Hombach-Klonisch S
    Thyroid; 2015 May; 25(5):514-27. PubMed ID: 25744544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. V domain of RAGE interacts with AGEs on prostate carcinoma cells.
    Allmen EU; Koch M; Fritz G; Legler DF
    Prostate; 2008 May; 68(7):748-58. PubMed ID: 18302220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pentamidine niosomes thwart S100B effects in human colon carcinoma biopsies favouring wtp53 rescue.
    Seguella L; Rinaldi F; Marianecci C; Capuano R; Pesce M; Annunziata G; Casano F; Bassotti G; Sidoni A; Milone M; Aprea G; de Palma GD; Carafa M; Pesce M; Esposito G; Sarnelli G
    J Cell Mol Med; 2020 Mar; 24(5):3053-3063. PubMed ID: 32022398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lysozyme as the anti-proliferative agent to block the interaction between S100A6 and the RAGE V domain.
    Khan MI; Dowarha D; Katte R; Chou RH; Filipek A; Yu C
    PLoS One; 2019; 14(5):e0216427. PubMed ID: 31071146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C-reactive protein (CRP) up-regulates expression of receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in THP-1 cells: inhibitory effects of atorvastatin.
    Mahajan N; Bahl A; Dhawan V
    Int J Cardiol; 2010 Jul; 142(3):273-8. PubMed ID: 19201044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. S100B-stimulated NO production by BV-2 microglia is independent of RAGE transducing activity but dependent on RAGE extracellular domain.
    Adami C; Bianchi R; Pula G; Donato R
    Biochim Biophys Acta; 2004 Dec; 1742(1-3):169-77. PubMed ID: 15590067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of αX I-Domain Binding to Receptors for Advanced Glycation End Products (RAGE).
    Buyannemekh D; Nham SU
    Mol Cells; 2017 May; 40(5):355-362. PubMed ID: 28535664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. S100 protein translocation in response to extracellular S100 is mediated by receptor for advanced glycation endproducts in human endothelial cells.
    Hsieh HL; Schäfer BW; Weigle B; Heizmann CW
    Biochem Biophys Res Commun; 2004 Apr; 316(3):949-59. PubMed ID: 15033494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suramin blocks interaction between human FGF1 and FGFR2 D2 domain and reduces downstream signaling activity.
    Wu ZS; Liu CF; Fu B; Chou RH; Yu C
    Biochem Biophys Res Commun; 2016 Sep; 477(4):861-867. PubMed ID: 27387234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pentamidine inhibit S100A4 - p53 interaction and decreases cell proliferation activity.
    Katte RH; Chou RH; Yu C
    Arch Biochem Biophys; 2020 Sep; 691():108442. PubMed ID: 32649952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of RAGE signaling through the intracellular delivery of inhibitor peptides by PEI cationization.
    Putranto EW; Murata H; Yamamoto K; Kataoka K; Yamada H; Futami J; Sakaguchi M; Huh NH
    Int J Mol Med; 2013 Oct; 32(4):938-44. PubMed ID: 23934084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction between S100P and the anti-allergy drug cromolyn.
    Penumutchu SR; Chou RH; Yu C
    Biochem Biophys Res Commun; 2014 Nov; 454(3):404-9. PubMed ID: 25450399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4: Role of the receptor for advanced glycation end products.
    Yammani RR; Carlson CS; Bresnick AR; Loeser RF
    Arthritis Rheum; 2006 Sep; 54(9):2901-11. PubMed ID: 16948116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.